In addition to providing state-of-the-art diagnostic services, the pathology department continues to publish their advances in research and diagnostics. We invite you to browse some of our faculty’s most notable publications.
- Diagnosis of upper tract urothelial carcinoma – a comparative study of urinary cytology and surgical biopsy, Lu Wang, MD, Stefan E. Pambuccian, MD, Eva M. Wojcik, MD, and Guliz A. Barkan, MD, Journal of the American Society of Cytopathology
- What should not be reported as atypia in urine cytology, Eva M. Wojcik, MD, Journal of the American Society of Cytopathology.
- What is atypia? Use, misuse and overuse of the term atypia in diagnostic cytopathology, Stefan E. Pambuccian, MD, Journal of the American Society of Cytopathology.
- Evidence-based adequacy criteria for urinary bladder barbotage cytology, Jennifer Prather MD, Brent Arville DO, Grazina Chatt CT, Stefan E. Pambuccian MD, Eva M. Wojcik MD, Marcus L. Quek MD and Guliz A. Barkan MD, Journal of the American Society of Cytopathology
- Is a consistent cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytologic specimens possible? A comparison between cytomorphologic features of low-grade urothelial carcinoma and non-neoplastic changes shows extensive overlap, making a reliable diagnosis impossible, Zulfia McCroskey MD, Stephanie Kliethermes PhD, Burak Bahar MD, Guliz A. Barkan MD, Stefan E. Pambuccian MD and Eva M. Wojcik MD, Journal of the American Society of Cytopathology
- P16 expression predicts necrotic response among patients with osteosarcoma receiving neoadjuvant chemotherapy. Dariusz Borys, MD.
- Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity. Dariusz Borys, MD.
- Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markers. Dariusz Borys, MD.